Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ponatinib in Philadelphia chromosome-positive leukemias.

× No keyword cloud information.

6 in total

1. The evolution of dasatinib dosage over the years and its relevance to other anticancer medications.

Authors: Charles A Schiffer
Journal: Cancer Date: 2018-05-03 Impact factor: 6.860

2. Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients.

Authors: H Hjorth-Hansen; J Stentoft; J Richter; P Koskenvesa; M Höglund; A Dreimane; K Porkka; T Gedde-Dahl; B T Gjertsen; F X Gruber; L Stenke; K M Eriksson; B Markevärn; A Lübking; H Vestergaard; L Udby; O W Bjerrum; I Persson; S Mustjoki; U Olsson-Strömberg
Journal: Leukemia Date: 2016-05-02 Impact factor: 11.528

Review 3. Best Practices in Chronic Myeloid Leukemia Monitoring and Management.

Authors: Simona Soverini; Caterina De Benedittis; Manuela Mancini; Giovanni Martinelli
Journal: Oncologist Date: 2016-03-31

Review 4. Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.

Authors: Federico Lussana; Alessandro Rambaldi
Journal: Mediterr J Hematol Infect Dis Date: 2014-11-01 Impact factor: 2.576

5. DFG-out mode of inhibition by an irreversible type-1 inhibitor capable of overcoming gate-keeper mutations in FGF receptors.

Authors: Zhifeng Huang; Li Tan; Huiyan Wang; Yang Liu; Steven Blais; Jingjing Deng; Thomas A Neubert; Nathanael S Gray; Xiaokun Li; Moosa Mohammadi
Journal: ACS Chem Biol Date: 2014-10-27 Impact factor: 5.100

Review 6. Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors.

Authors: Mark Reinwald; Tobias Boch; Wolf-Karsten Hofmann; Dieter Buchheidt
Journal: Biomark Insights Date: 2016-04-21

6 in total